PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
November 18, 2010 | ISSUE NUMBER 175 VOL 8

Healthcare Spending
The Potential Pain of Deficit Reduction
US National Commission on Fiscal Responsibility Co-Chair’s report signals further cost controls on medicines—including a global budget—beyond what is ordered up in Obamacare.

Legal
Justice to Pharma: “Do the Perp Walk!”
Former GSK counsel is the first target in government’s executive-liability crackdown. Could J&J be next?

Innovative Contracting
Wins and Losses from Risk-Sharing Agreements
Risk-sharing agreements—standard in Australia and taking root in Europe—are now attracting significant attention in the US.

Layoffs
Roche Joins the Roll Call of Big Pharma Layoffs
The 4,800 job cuts announced by the Swiss drugmaker is bad news for its US employees.

// Topaz Pharmaceuticals (Horsham, Pa.) named Bob Radie as President and CEO. Thomas Beck, M.D., who was serving as interim CEO, resumed his role as Chief Medical Officer. // Neoprobe Corp. (Dublin, Ohio) named Dr. Mark Pykett as Executive Vice President and Chief Development Officer. // Robert Kamen, PhD, joined Third Rock Ventures (Boston) as an Entrepreneur-in-Residence. // Susan Doré joined HC&B (Austin, Texas) as Senior Interactive Project Manager. //

Dec 5–7: Mayo Clinic 2010 Symposium: Achieving the Vision — Advancing High-Value Health Care
Bethesda, MD


Dec 8–9: CMAC 2010 – Commercialization and Market Access Congress Orlando, FL

Jan 11–12, 2011: The State of Clinical Development Costs Philadelphia, PA


 
FindPharma  
Search  

Survey
Do you think the Department of Justice will bring criminal charges against any big-name pharma executives?
Click To Vote
 
 

 

Quick Links

Memo to Congress: Hands Off FDA

New World Health Organization Guidelines on Generics

Patient Education Videos That Work


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive